MYD88 and neoplasm: Moreover, in most cases of Waldenström’s macroglobulinemia, a low-grade B-cell neoplasm that invades bone marrow and secretes monoclonal IgM, MYD88 L265P mutations were observed20, indicating MYD88 enhances tumour development as well as generating TICs.